David Jeffs - Dec 29, 2023 Form 4 Insider Report for Cell MedX Corp. (CMXC)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: David Jeffs
Stock symbol: CMXC
Transactions as of: Dec 29, 2023
Transactions value $: $622,718
Form type: 4
Date filed: 1/10/2024, 01:10 PM
Previous filing: Jan 9, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMXC	Common Shares	Award	$518K	+74M		$0.01^*	74M	Dec 29, 2023	Direct	F1
transaction	CMXC	Common Shares	Purchase	$52.5K	+7.5M	+10.14%	$0.01^*	81.5M	Dec 29, 2023	Daughter	F2
transaction	CMXC	Common Shares	Purchase	$52.5K	+7.5M	+9.21%	$0.01^*	89M	Dec 29, 2023	Son	F2

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	(1) Reporting Person acquired 73,959,726 shares on settlement of $517,718 owed by the Issuer to the Reporting Person.
F2	Immediate family members of the Reporting Person acquired a total of 15,000,000 shares on settlement of $105,000 owed by the Issuer to the immediate family members. The inclusion of these shares shall not be deemed an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.